Clinical Trials List
2023-10-01 - 2033-02-05
Phase III
Recruiting8
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李蕙鳴 Division of General Surgery
- Meng-Jer Hsieh Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- 洪朝明 Division of General Surgery
- 魏敬庭 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 周旭桓 Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- Li-Yu Lee Division of Others -
- 沈士哲 Division of General Surgery
- 何蕙余 無
- Chan-Keng Yang Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- Wen-Ling Kuo Division of General Surgery
- Yung-Chang Lin Division of Hematology & Oncology
- Chun-Hsiu Liu Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jui-Hung Tsai 無
- Kuo-Ting Lee Division of General Surgery
- 楊舜如 無
- Yao-Lung Kuo 無
- 黃怡菁 無
- Chun-Hui Lee 無
- Zhu-Jun Loh Division of General Surgery
- 黃怡菁 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Cheng Huang Division of General Surgery
- 陳彥蓁 Division of General Surgery
- 賴亦貞 Division of Radiology
- 邱仁輝 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 馮晉榮 無
- 許志怡 Division of Others
- 林燕淑 Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- 鄭涵方 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 郭懿萱 Division of Ophthalmology
- 陳柏方 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-SHEN LU Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- 黃柏翔 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 蔡立威 Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- 李宜軒 Division of Others
- 林季宏 Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 魏以宣 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- 蘇孟夏 Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
1900 participants
